[Federal Register Volume 75, Number 60 (Tuesday, March 30, 2010)]
[Notices]
[Page 15713]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-6970]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities; Office of Science Policy; 
Office of the Director; Notice of a Meeting of the NIH Blue Ribbon 
Panel

    The purpose of this notice is to inform the public about a meeting 
of the NIH Blue Ribbon Panel to Advise on the Risk Assessment of the 
National Emerging Infectious Diseases Laboratories at Boston University 
Medical Center. The meeting will be held on Wednesday, April 28, 2010, 
at the Boston Marriott Copley Place, 110 Huntington Avenue, Boston, 
Massachusetts 02116 from approximately 6:30 p.m. to 9:45 p.m.
    The Blue Ribbon Panel is holding a public meeting to update the 
community on the status and proposed approach of the study. The meeting 
program will include presentations providing an overview of the risk 
assessment process, as well as breakout sessions in which more detailed 
presentations and dialogue about the proposed approach will take place.
    Members of the public may, at any time, file written comments to 
the following address: NIH Blue Ribbon Panel, Office of the Director, 
National Institutes of Health, Mail Stop Code 7985, Bethesda, MD 20892-
7985 or by sending an e-mail to: [email protected].
    An agenda and slides for the meeting may be obtained prior to the 
meeting by connecting to http://nihblueribbonpanel-bumc-neidl.od.nih.gov/. For additional information concerning this meeting, 
please contact Ms. Laurie Lewallen, Advisory Committee Coordinator, 
Office of Biotechnology Activities, Office of Science Policy, Office of 
the Director, National Institutes of Health, 6705 Rockledge Drive, Room 
750, Bethesda, MD 20892-7985; telephone 301-496-9838; e-mail 
[email protected].

    Dated: March 24, 2010.
Amy P. Patterson,
Director, Office of Biotechnology Activities, National Institutes of 
Health.
[FR Doc. 2010-6970 Filed 3-29-10; 8:45 am]
BILLING CODE 4140-01-P